Alta Life Sciences
Alta Life Sciences is a Barcelona-based, multistage venture capital investment firm founded in 2016, focused on the life sciences sector in Spain and broader Europe, with a small team operating alongside leading European biotech investors.
- Company typePrivate
- Founded2016
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Alta Life Sciences does
Alta Life Sciences is a Barcelona-based, multistage venture capital investment firm focused on the life sciences sector, founded in 2016. The firm operates with a small team (1-10 employees) and is positioned within the Iberian and broader European biotech investment ecosystem, as evidenced by its participation as an existing investor in Ona Therapeutics' $86.6 million oversubscribed Series B financing round alongside a syndicate of leading life sciences investors including Columbus Venture Partners, Mérieux Equity Partners, Ysios Capital, Asabys Partners, Bpifrance, CDTI, COFIDES, Korys, and FundPlus NV.
The firm's investment focus targets innovative biotechnology companies, with the Ona Therapeutics portfolio company developing antibody-drug conjugates (ADCs) for treatment-resistant cancers, specifically ONA-255 for breast cancer and ONA-389 for colorectal cancer. As a private, early- to growth-stage investor, Alta Life Sciences derives economics from traditional VC fund mechanics — management fees on committed capital and carried interest on exits — though specific fund sizes, AUM, portfolio composition beyond disclosed investments, and LP composition are not visible in the source data.
Public disclosures on the firm's operations are minimal; the available data captures the firm solely through its investee relationship with Ona Therapeutics. No founding partners, leadership team, fund vintages, or broader portfolio companies are described in the source material, limiting deeper assessment of strategy, track record, or organizational structure.
Alta Life Sciences firmographics
Firmographics- Name
- Alta Life Sciences
- Website
- https://altals.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Alta Life Sciences is a Barcelona-based, multistage venture capital investment firm founded in 2016, focused on the life sciences sector in Spain and broader Europe, with a small team operating alongside leading European biotech investors.
- Ownership category
- akta.pro rank
Alta Life Sciences industry classification
Industry- Product category
- Life Sciences Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
- akta.pro secondary industry
- Technology & Software Growth Equity (FSANACAA)
Keywords
Where Alta Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Markets served
Alta Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Alta Life Sciences product offering
Product offeringCore offering
Alta Life Sciences is a Barcelona-based venture capital firm that invests across multiple stages in life sciences and biotechnology companies. The firm provides growth capital to therapeutics developers, as evidenced by its participation as an existing investor in Ona Therapeutics' $86.6 million oversubscribed Series B financing round in June 2026, alongside other institutional healthcare investors.
Differentiator
Problem solved
Functional benefit
Products and services
- Multistage Life Sciences Venture Capital Fund A venture capital fund vehicle that provides growth-stage equity capital to life sciences and biotechnology companies, including oversubscribed Series B financings targeting therapeutic platforms such as antibody-drug conjugates. Intended for private biotech and life sciences companies seeking institutional investment partners.
Companies that use Alta Life Sciences
Customer profileIdeal customer profiles1 record
Alta Life Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Alta Life Sciences partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Alta Life Sciences competitors and assessment
Company assessmentDirect peers
- Ysios Capital: Spanish multistage life sciences VC firm headquartered in Barcelona/San Sebastián. Co-invested alongside Alta Life Sciences in Ona Therapeutics' Series B; most directly comparable peer by geography, fund size, and biotech focus.
- Asabys Partners: Barcelona-based venture capital firm investing in life sciences (biopharma, medtech, digital health). Co-invested in Ona Therapeutics' Series B; directly comparable as a Spanish life sciences specialist VC.
- Columbus Venture Partners: Spanish venture capital manager specialised in life sciences, co-led Ona Therapeutics' $86.6M Series B. Directly comparable as a Spanish biotech VC with similar stage and sector focus.
- Mérieux Equity Partners: Lyon-based growth equity firm dedicated to healthcare and life sciences, co-led the Ona Therapeutics Series B. Directly comparable as a European life sciences investor with cheque sizes overlapping Alta's.
- Kurma Partners: Paris-based venture capital firm investing across the life sciences value chain (biotech, medtech, digital health). Directly comparable as a European specialist life sciences VC.
- Sofinnova Partners: One of Europe's largest life sciences-dedicated VCs, active across biotech and medtech. Directly comparable as a European life sciences specialist with multistage strategy.
- Forbion: Dutch life sciences VC firm backing late-stage biotech and medical companies. Directly comparable as a European life sciences specialist investing at venture and growth stages.
- HealthCap: Nordic/European life sciences venture capital investor active in therapeutics and medtech. Directly comparable as a European biotech-focused multistage VC.
- EQT Life Sciences (formerly LSP): Amsterdam-based life sciences investor (now part of EQT) covering venture and growth stages in biotech and medtech. Directly comparable as a European life sciences specialist VC with similar stage and ticket sizes.
Broad incumbents
- Bpifrance: France's public investment bank with large life sciences activities across venture, growth, and direct equity. Co-invested in Ona Therapeutics' Series B; broad incumbent providing capital at scale across the European life sciences stack.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Alta Life Sciences social profiles
Digital presenceAlta Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alta Life Sciences leadership team
Management profileNumber of profiles
Alta Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alta Life Sciences M&A and investment
M&A and investmentM&A
Investments18 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alta Life Sciences
What does Alta Life Sciences do?
Alta Life Sciences is a Barcelona-based venture capital firm that invests across multiple stages in life sciences and biotechnology companies. The firm provides growth capital to therapeutics developers, as evidenced by its participation as an existing investor in Ona Therapeutics' $86.6 million oversubscribed Series B financing round in June 2026, alongside other institutional healthcare investors.
Is Alta Life Sciences a public or private company?
Alta Life Sciences is a private company. It is classified as unknown and is currently operating.
When was Alta Life Sciences founded?
Alta Life Sciences was founded in 2016. It employs 1 to 10 people.
Where is Alta Life Sciences based?
Alta Life Sciences is headquartered in Barcelona, Spain, in the Europe region.
Who are Alta Life Sciences's main competitors?
Direct peers on record are Ysios Capital, Asabys Partners, Columbus Venture Partners, Mérieux Equity Partners, Kurma Partners, Sofinnova Partners, Forbion, HealthCap and EQT Life Sciences (formerly LSP). Bpifrance is listed as a broad incumbent.
Does Alta Life Sciences have an API?
No public API is recorded for Alta Life Sciences.
What industry is Alta Life Sciences in?
Alta Life Sciences's product category is Life Sciences Venture Capital. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.